There's the ISCT Annual Meeting (conference) happening as we "speak" (so-to-speak). Minaris Advanced Therapies feature prominently in the speakers list. There's quite a few subjects being covered that would have relevance to CHM's pipeline esp our CDH17 trial.
There's a one-day training workshop focused on Cell Manufacturing Strategy & Optimization - which aligns perfectly with Bec's position, CHM's progress and goals.
The compilation of the blood analyses of the CDH17 patients would likely be underway over there too. MDA should be an exciting visit also.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.4¢ | $15.69K | 3.919M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 21936206 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 24685267 | 27 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |